Pacific Biosciences of California, Inc. (BMV:PACB)

Market Cap	6.74B +1.4%
Revenue (ttm)	2.88B +5.0%
Net Income	-2.32B
EPS	-7.67
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32
Average Volume	1,043
Open	27.50
Previous Close	27.50
Day's Range	27.50 - 27.50
52-Week Range	22.22 - 31.00
Beta	n/a
RSI	n/a
Earnings Date	May 7, 2026

About BMV:PACB

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified...

• Founded: 2000
• Employees: 485
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PACB

Financial Performance

In 2025, BMV:PACB's revenue was $160.01 million, an increase of 3.89% compared to the previous year's $154.01 million. Losses were -$546.38 million, 76.3% more than in 2024.

Financial numbers in USD